ClinConnect ClinConnect Logo
Search / Trial NCT06093724

Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV)

Launched by UNIVERSITY HOSPITAL, LIMOGES · Oct 17, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Mt F, Transgender, Vaginoplasty, Penoscrotal Inversion, Mri

ClinConnect Summary

This clinical trial, called TRANSPELV, is studying how the body changes after a specific type of surgery for transgender women (those assigned male at birth who identify as female). The researchers want to see how the area around the pelvic and perineal region evolves over time, particularly looking for a condition called rectocele, which can happen when the rectum bulges into the vagina. They will use special imaging called MRI to take pictures of this area before surgery and again at 6 and 24 months after the procedure.

To participate in this trial, individuals need to be at least 18 years old and scheduled for a vaginoplasty surgery at Limoges' University Hospital. It's important that they have social security coverage and provide written consent to join the study. However, those who are having different types of surgeries or cannot undergo an MRI will not be eligible. Participants can expect to have their MRI scans done at the specified times and will help researchers learn more about the effects of this surgery on the body.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Patient over 18 years old
  • Patient admitted in urology ward at Limoges' University Hospital for MtF sexual reassignment surgery by vaginoplasty
  • Patient affiliated or benefitting from a social security system
  • Patient free, informed, written and signed consent
  • Exclusion Criteria:
  • Patient admitted for vulvoplasty surgery
  • Patient admitted for second vaginoplasty surgical gesture
  • Contraindication of realizing an MRI

About University Hospital, Limoges

The University Hospital of Limoges is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates patient care with cutting-edge research initiatives, fostering collaboration among healthcare professionals, researchers, and academic partners. With a commitment to improving patient outcomes and contributing to medical knowledge, the University Hospital of Limoges plays a pivotal role in translating scientific discoveries into effective therapeutic strategies. Its state-of-the-art facilities and expertise in various medical fields ensure rigorous trial management and adherence to ethical standards.

Locations

Limoges, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported